Healthcare Providers and Services
Company Overview of Houston Methodist Hospital
Houston Methodist Hospital operates as a nonprofit healthcare organization. The company, through its hospitals, engages in diagnosing, treating, and researching various types of cancer, including bladder cancer, breast, colon, ovarian and uterine, lung, prostate, skin, stomach and intestinal, testicular, and thyroid cancer; and offers brain and pituitary tumors, leukemia, and lymphoma diagnosing, treating, and researching services. It also provides diabetes and weight management research, prevention, and management services; personalized care for individuals with obesity, high blood pressure, diabetes, or lipid disorders; services for heart and vascular diseases; neurology and neurosurgery s...
6565 Fannin Street
Houston, TX 77030
Founded in 1919
Key Executives for Houston Methodist Hospital
Chief Executive Officer and President
Chief Executive Officer of Woodlands Hospital
President of Medical Staff and Member of The Board of Directors
Compensation as of Fiscal Year 2014.
Houston Methodist Hospital Key Developments
Houston Methodist Names Debbie Sukin as CEO of New Woodlands Hospital
Jun 30 14
Houston Methodist has named Debbie Sukin to be the CEO of its Woodlands hospital. She has been serving as the CEO of the St. Luke's The Woodlands hospital for the past 10 years. Previously, she ran Houston Methodist's Debakey Heart & Vascular Center. She will be responsible for the oversight of the construction and will be in charge of day-to-day operations once the facility is open. The new hospital, which will open in early 2015, is located at Highway 242 and Interstate 45. The eighth hospital in tche system's chain will be 470,000 square feet and cost around $328 million.
Houston Methodist Enters an Exclusive Agreement with Facts & Figures LLC to License its High-Definition, Multidimensional Imaging Technology
Jan 15 14
Houston Methodist has entered an exclusive agreement with Facts & Figures LLC, to license its high-definition, multidimensional imaging technology known as Plato's CAVE (Computer Augmented Virtual Environment). The agreement allows Facts and Figures to develop and commercialize Plato's CAVE technologies internationally. By combining CT, MRI and PET scans, surgeons use Plato's CAVE to better determine their surgical approach. They can view any aspect of a patient's body in multiple dimensions, in still images or video. Plato's CAVE creates 3D, 4D, 5D, or 6D images that allow surgeons to plan the safest, fast route to a tumor or blood vessel; to measure blood flow through the heart; to ensure there are no unexpected developments during the operation; and to even interpret sounds in the patient's body. The personalized visualization platform incorporates interface technologies, such as voice recognition, motion sensors, game controllers and multi-touch tables that look similar to a giant smartphone. By combining different scans, physicians can not only see through skin, muscle, bones and organs, but they can also take measurements that aid in the clinical data sets to help with diagnosis and surgical planning.
Celgene Corporation Enters into Separate Strategic Collaboration with the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and the Methodist Hospital to Develop Existing and New Products and Programs in the CAR T-Cell Field
Mar 21 13
Celgene Corporation has entered into a separate strategic collaboration in the CAR T-cell field with the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and The Methodist Hospital, Houston, led by Malcolm Brenner, M.D., Ph.D., professor, Department of Molecular and Human Genetics and the director, Center for Cell and Gene Therapy. bluebird bio, Celgene and Dr. Brenner's team will work collaboratively to advance and develop existing and new products and programs in the CAR T-cell field.
Similar Private Companies By Industry
Recent Private Companies Transactions